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Background: Expression of Ror2 leads to increased tumorigenicity in RCC.
Results: Ror2 expression stabilizes an increased pool of soluble -catenin, which enhances the response to Wnt stimulation.
Conclusion: Ror2 promotes basal and canonical Wnt3a ligand-enhanced -catenin signaling in RCC.
Significance:This work demonstrates a novel Ror2-dependent tiered state of canonicalWnt signaling, promoting basal signals
and priming RCC cells for a heightened response to the ligand.
Expression of the receptor tyrosine kinase-like orphan recep-
tor 2 (Ror2) has been identified in an increasing array of tumor
types and is known to play a role as an important mediator of
Wnt signaling cascades. In this study, we aimed to clarify Ror2
interactions with the Wnt pathways within the context of renal
cell carcinoma (RCC). An examination of Ror2 expression in
primary human RCC tumors showed a significant correlation
with several Wnt signaling genes, including the classical feed-
back target gene Axin2. We provide evidence that Ror2 expres-
sion results in a partially activated state for canonical Wnt sig-
naling through an increased signaling pool of-catenin, leading
to an enhancement of downstream target genes following
Wnt3a stimulation in both renal and renal carcinoma-derived
cells. Additionally, inhibition of low-density lipoprotein recep-
tor-related protein 6 (LRP6) with either siRNA or dickkopf
decreased the response to Wnt3a stimulation, but no change
was seen in the increased -catenin pool associated with Ror2
expression, suggesting that LRP6 cofactor recruitment is neces-
sary for a Wnt3a-induced signal but that it does not participate
in theRor2 effect on-catenin signaling. These results highlight
a new role for Ror2 in conveying a tonic signal to stabilize solu-
ble -catenin and create a poised state of enhanced responsive-
ness to Wnt3a exogenous signals in RCC.
Cancer cells usurp many normal signaling processes in the
course of transformation or acquisition of transformed cell
traits. The Wnt signaling pathway is a growth and differentia-
tion control pathway central to embryogenesis and cancer (1).
The canonical Wnt pathway is characterized by secreted Wnt
factors, with Wnt3a being the most widely studied, engaging
the receptor complex consisting of low-density lipoprotein
receptor-related protein (LRP)2 and a member of the Frizzled
(Fzd) family of receptors, halting the basal state of ubiquitina-
tion and degradation of -catenin within the destruction com-
plex. As -catenin becomes stabilized, it results in the satura-
tion of the destruction complex, leading to an increase of
cytosolic -catenin and localization to the nucleus (2). Nuclear
-catenin drives the transcription of genes involved in promot-
ing cell proliferation, maintenance of a primitive state, or
inducing differentiation dependent upon cellular context.
Wnts can initiate other signaling processes, known as the non-
canonical Wnt signaling pathways and promote migration,
establishment of polarity, or programming of morphogenesis
(3). In tumors, these pathways provide signals for cancer cells to
proliferate, acquire stem cell-like properties, and secure inva-
sive characteristics as a result of mutations or differential
expression of key members of these pathways.
One of the recently described non-canonical Wnt receptors,
the receptor tyrosine kinase-like orphan receptor 2 (Ror2), has
been implicated in a diverse set of cancers (4–9), including
renal cell carcinoma (RCC), where the aberrant expression
occurs as a result of the constitutive deregulation of the hypoxia
response pathway resulting from loss of the von Hippel-Lindau
(VHL) gene (4, 10). Ror2 is best known for its role in bone
morphogenesis becausemutation or loss of this protein in early
embryogenesis results in limb foreshortening in humans and
mouse models (11–13). The expression of Ror2 in mice is
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restricted to early gestation and mesenchymal stem cell niches
(14, 15). Ror2 is emerging as an intriguing mediator of various
context-specific Wnt signals in developmental processes as
well as cancer (16–18). Ror2 has been shown to engage both
canonical and noncanonical Wnts, and it has been shown to
transmit signals related to convergent extension movements,
planar cell polarity, and proliferation (19, 20). Ror2 engagement
of Wnt5a has been shown to inhibit canonical signaling. How-
ever, recent work utilizing primary cell lines showed this effect
to be Ror2-independent (18, 21). The ability of Ror2 to convey
situation-appropriate signals likely involves the availability of
cofactors, binding partners, or downstream substrates to affect
the signal and functional outcome and may contribute to cell
type- or situation-specific effects.
Although we have shown previously that Ror2 expression is
associated with cellular migration and invasion phenotypes in
renal carcinoma cells, growth of RCC is also facilitated by
-catenin transcription-mediated canonical signals (22). The
mediators of this signal are thought to be dependent on the lost
expression of the vonHippel-Lindau tumor suppressor (23, 24).
Therefore, we decided to explore the signaling pathways related
to Ror2 expression in renal carcinoma- and renal-derived cel-
lular systems. Here, we demonstrate that human RCC tumors
and cell lines show concordance of Ror2 expressionwith a large
number of established canonical Wnt pathway targets, sugges-
tive of a role of Ror2 in mediating -catenin-dependent signal-
ing. Expression of Ror2 increased the stabilization of -catenin
as well as the transcriptional activity of canonical Wnt target
genes, independently of exogenously added Wnt3a, and led to
the enhancement of the canonical signal when exogenous
Wnt3a was supplied. Inhibition of the canonical coreceptor
LRP6 reduced the responsiveness to Wnt3a. However, it did
not ablate the Wnt3a-independent increase in -catenin.
Mutations in the kinase domain of Ror2 abrogated the stabili-
zation of -catenin and Axin2 transcription observed with
expression of wild-type protein. These findings demonstrate a
novel LRP-independent function of Ror2 to maintain an
increased signaling pool of stable -catenin in renal cells while
priming cells for additional responsiveness toWnt3a activation
of the -catenin transcriptional pathway.
EXPERIMENTAL PROCEDURES
Cell Culture—786-0 and the derivative cell lines 786-0 RC3
(25) and 786-0 pRS, stable monoclonal knockdown 786-0
shRor2.1 and shRor2.2 (4) cells, 786-0 Tap-hRor2 cells, and
HEK293T cells were grown inDMEMwith 10%FBS, nonessen-
tial amino acids, L-glutamine, and penicillin/streptomycin. L
cells and Wnt3a-producing L cells were grown in DMEM with
10% FBS. Control and Wnt3a-conditioned medium (CM) was
collected at 24 and 48 h after cells reached confluency. 786-0 cells
were transfectedwithTAP-hRor2andselectedwith1g/mlpuro-
mycin to generate polyclonal stable lines. HEK293T and 786-0
cells were transducedwith lentiviruses carrying the eGFP control,
TRE(tight)-eGFP-pEF1a-rtTA-IRES-Puro or hRor2-eGFP, TRE-
(tight)-hRor2eGFP-pEF1a-rtTA-IRES-Puro,with stable lines gen-
erated following selection with 1 g/ml puromycin.
Plasmids—The TAP-hRor2 was generated with hRor2
cloned into the pIRESpuro-GLUE backbone (26). The control
TRE(tight)-eGFP-pEF1a-rtTA-IRES-PuroandTRE-tight-hRor2-
eGFP-eF1a-rtTA-IRES-Puro vectors were generated with eGFP
alone or the fusion hRor2-eGFPbeing cloned into a PHAGE6 len-
tiviralbackbone (27).ExpressionofeGFPorhRor2-eGFPwascon-
firmed visually 48 h after induction with doxycycline (500 ng/ml).
Site-directed mutagenesis using a QuikChange II site-directed
mutagenesis kit (Agilent Technologies, La Jolla CA) was used to
introduce the amino acid substitutions K507M and D633A for
hRor2-eGFP-DM.
siRNA—Stealth siRNA for LRP6 (5-ACGCAGCAUUGAG-
CGUGCCAACAAA-3 and 5-GAUCCCAUGGUUGGGUA-
CAUGU AUU-3) were pooled, and Stealth negative control
siRNA (Stealth RNAi negative control low GC duplex) was
introduced into cells using Lipofectamine RNAiMAX (Invi-
trogen) according to the instructions of the manufacturer
and allowed to incubate for 48 h.
Quantitative RT-PCR and Human Wnt Signaling RT2 Pro-
filer PCR Array—Total RNA was extracted from cells using a
Qiagen RNeasy mini kit (Valencia, CA). cDNA was made from
500 ng of total RNA using random primers (Invitrogen) and
Superscript II RT-PCR reagents (Invitrogen) and analyzed
using the ABI 7900HT fast real-time PCR system with the fol-
lowing proprietary FAM-labeled primers: Ror2, Axin2, Fzd1,
Jun, 18S, and -actin (Applied Biosystems, Foster City, CA).
Wnt-related gene expression was examined with the human
Wnt signaling RT2 Profiler PCR array (SABiosciences, Freder-
ick, MD) using cDNA from 786-0 TAP-hRor2, 786-0, and
786-0 shRor2.2 cells with the ABI 7500 real-time PCR system.
Changes in gene expression were calculated following normal-
ization to an internal pool of five housekeeping genes. Axin2
was not available in the RT2 Profiler PCR array.
Immunoblotting—Cells were lysed in 10 mM Tris (pH 7.4),
100 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1 mM NaF, 20 mM
Na4P2O7, 2mMNa3VO4, 1% Triton X-100, 10% glycerol, 0.1%
SDS, 0.5% deoxycholate, 1 mM PMSF, and a protease inhibitor
mixture (Roche Diagnostics, Indianapolis IN) and quantitated
using Bradford reagent to measure absorbance at 595 nm.
Lysates were separated by SDS-PAGE, transferred to nitrocel-
lulose membranes (GE Healthcare, Pittsburg, PA), and evalu-
ated using the following antibodies: Ror2 (catalog no. AF2064,
R&D Systems, Minneapolis, MN); DVL2 (catalog no. 3216),
DVL3 (catalog no. 3218), LRP6 (catalog no. 3395), and pLRP6
(catalog no. 2568, Cell Signaling Technology, Danvers, MA);
Ku80 used as loading control (catalog no. ab1273, Abcam,
Cambridge, MA); and -catenin (catalog no. C2206, Sigma-
Aldrich, St. Louis,MO). For all immunoblot analyses, following
incubation with corresponding secondary antibodies conju-
gated to IR dye 680 or 800, membranes were scanned using the
Odyssey IR imager (LI-COR Biosciences, Lincoln, NE) with
densitometric analysis performed using Odyssey v3.0.21.
Concanavalin-A Separation of Cytosolic -Catenin—Cells
were incubated for 1 h with control-conditioned medium,
Wnt3a-conditioned medium (1:2 dilution), or DKK1 (400
ng/ml, R&D Systems). 50 g of protein lysates from each sam-
ple as determined by Bradford assay were rotated with 10 l of
prepared concanavalin A-Sepharose 4b beads (GE Healthcare)
overnight at 4 °C. Supernatants were removed following a brief
centrifugation and analyzed by SDS-PAGE.
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Luciferase Assays—To determine the activity of canonical
Wnt signaling in the RCC cells, 786-0 and HEK293T cells were
transfected with TOPFlash and constitutive pHRG-Renilla
luciferase reporters. 24 h post-transfection, cells were
seeded in triplicate, with medium being replaced after 8 h
with serum-free medium and incubated for 20 h. Post-serum
starvation, cells were treated with control PBS or recombi-
nant human Wnt3a (100 ng/ml, R&D Systems) and incu-
bated for 24 h. Luciferase activity was measured from lysed
samples using a luminometer and the Dual-Luciferase
reporter assay system (Promega, Madison, WI). Relative
luciferase units were calculated by the ratio of TOPFlash
luciferase activity to internal Renilla luciferase activity for
each sample.
Microarray Analysis—Gene expression for 95 human RCC
tumors was downloaded and prepared as described previously
(28). Collection and analysis of these tumors was approved by
the institutional biomedical ethics review committee. Signifi-
cance of analysis of microarrays was used to determine genes
that significantly correlated with Ror2 expression among the
95 humanRCC tumorswith a false discovery rate 0.043% and
analyzed using Database for Annotation, Visualization and
Integrated Discovery (DAVID) to identify significantly enriched
gene ontologies.
Statistical Analysis—One-wayANOVAwas used to generate
p values in the comparison of each experimental condition
with the control. A p value of 0.05 was considered to be
significant and  0.001 to be highly significant. All error bars
shown are the calculated S.D. or S.E. across duplicate or
triplicate experiments.
RESULTS
Expression of Ror2 in Primary Human RCC Tumors Corre-
lates with Expression of Wnt Signaling Component Genes—We
established previously that Ror2 is expressed in RCC and con-
tributes to three-dimensional growth, migration, and in vivo
tumor growth (4). However, the role of Ror2 as aWnt receptor
in RCC remains largely unknown. Ror2 has been shown to
engage both canonical and non-canonical Wnt ligands (16–
18). We first sought to elucidate the dominant pattern of inter-
action of Ror2 with signaling networks through examination of
gene expression patterns from 95 human clear cell RCC
tumors. An analysis of transcript diversity was performed using
Agilent microarray data using significance of microarrays. This
evaluation yielded 723 genes (supplemental Table 1) that exhib-
ited a significant correlation or anticorrelation with Ror2 (false
discovery rate  0.043%). A heat map of these genes following
an unsupervised clustering exhibited two cluster patterns
correlating with the level of Ror2 transcript in these tumors
(Fig. 1A). A variety of significantly enriched gene ontologies
(supplemental Table 2) were identified, using DAVID, from
the genes exhibiting a positive correlation with Ror2. Similar
to previous results (4), Ror2 expression correlated withmany
genes playing a role in skeletal system development (GO
(Gene Ontology database): 0001501, p  6.11  1008) (Fig.
1B). In addition, enrichment for genes in the Wnt receptor
canonical signaling pathway (GO:0016055, p  2.6  104)
was also observed (Fig. 1C). These results suggest that the
role of Ror2 as a Wnt receptor in RCC tumors may not be
limited to non-canonical Wnt pathways.
FIGURE 1. Expression of Ror2 in primary human RCC tumors correlates with expression of Wnt signaling component genes. A, heat map of 721 probes
exhibiting significant (false discovery rate  0.043%) correlation and anticorrelation with Ror2 expression, as determined by significance of analysis of
microarrays in a panel of 95 primary human RCC tumors. Shown are magnified heat maps for the following significantly enriched gene ontologies identified
using DAVID from genes positively correlating with Ror2 expression, skeletal development (B), and the Wnt signaling pathway (C).
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Expression of Ror2 in RCCCells Results in Changes of Canon-
ical Wnt Regulators and Target Genes—Building on our find-
ings in our human RCC tumors, we examined the effects of
Ror2 expression on gene expression using the humanWnt sig-
naling RT2 Profiler PCR array (SABiosciences). The RCC-de-
rived cell line 786-0, which exhibits endogenous Ror2 expres-
sion, a derived shRNARor2 knockdown cell line, 786-0 shRor2,
and an overexpression cell line, 786-0 TAP-hRor2, were used to
determine alterations in gene expression under basal condi-
tions (Fig. 2A). We observed a large number of canonical genes
displaying concordant expression with Ror2 (Fig. 2B), suggest-
ing a potential association between Ror2 expression and the
activity of canonical -catenin transcriptional activity inde-
pendent of Wnt3a stimulation with exogenous ligand. This
concordant expression pattern with Ror2 was verified inde-
pendently for targets Fzd1 and Jun using independent samples
and primer pairs (Fig. 2, C and D).
Suppression of Ror2 Results in Decreased -Catenin-medi-
ated Transcription in RCC Cells—To more fully determine
whether the aberrant expression of Ror2 in RCC cells contrib-
utes to -catenin-dependent signaling, we used 786-0 cells,
which endogenously express Ror2. To directly examine canon-
FIGURE 2. Expression of Ror2 in RCC cells results in changes of canonical Wnt regulators and target genes. A, RNA expression was paneled across various
Wnt component and target genes using the human Wnt signaling RT2 Profiler PCR array with cDNA from 786-0 cells that endogenously express Ror2, 786-0
shRor2 where Ror2 is stably suppressed, and the Ror2 overexpression cell line 786-0  TAP-hRor2. Transcript values for each sample were normalized to the
geometric mean of five internal housekeeping genes. Changes in the level of expression correlating with Ror2 expression are displayed for the indicated 24
genes, with fold change calculated relative to 786-0. B, representative quantitative RT-PCR showing Ror2 expression levels for all 786-0 cell lines relative to
786-0. Quantitative RT-PCR shows a decrease in 786-0 shRNA Ror2 knockdown relative to 786-0 cells for FZD1 (C) and JUN (D). For all quantitative RT-PCR assays,
transcript values were normalized to the -actin RNA internal standard. Error bars represent S.E. across triplicates in triplicate experiments. p values were
calculated using one-way ANOVA. *, p  0.05; **,  0.001.
FIGURE 3. Suppression of Ror2 results in decreased -catenin-mediated transcription in RCC cells. Quantitative RT-PCR in 786-0 cells for Ror2 (A) shows
a significant increase in control RC3 cells with Wnt3a (100 ng/ml) stimulation, whereas levels were reduced significantly in both shRNA Ror2 knockdown cell
lines. B, likewise, a significant attenuation in Axin2 transcription in response to Wnt3a (100 ng/ml) is seen in both shRNA Ror2 knockdowns using quantitative
RT-PCR. For all quantitative RT-PCR assays, transcript values were normalized to an 18 S RNA internal standard, with fold change calculated in reference to
unstimulated 786-0 RC3. C, a significant reduction of -catenin-mediated transcriptional response following Wnt3a (100 ng/ml) stimulation with the TOPFlash
luciferase reporter in 786-0 Ror2-suppressed cells in comparison to control 786-0 pRS cells. Relative luciferase units (RLU) were calculated by normalizing
TOPFlash luciferase to internal Renilla luciferase activity. Error bars represent S.E. across triplicates in duplicate experiments. p values were calculated using
one-way ANOVA. *, p  0.05; **,  0.001.
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ical Wnt target gene activation in these cells, we first examined
the mRNA expression of a classic canonical Wnt target gene,
Axin2, using quantitative RT-PCR. Using two independent
shRNAs targeting unique domains of Ror2, we observed a sig-
nificant suppression of Ror2 (Fig. 3A) and of Axin2 transcrip-
tion following treatment with Wnt3a (B) in comparison with
the control empty vector (786-0 RC3), which also exhibited an
increase in Ror2 expression with Wnt3a stimulation. These
results were corroborated using the TOPFlash luciferase-re-
porter, where a 786-0 pRS (pRetroSuper) control showed a sig-
nificant induction of signal in response toWnt3a, but no induc-
tion was observed with shRor2 knockdown cell lines (Fig. 3C).
Overexpression of Ror2 Enhances -Catenin-mediated Tran-
scription in Renal and RCC Cells—Prior studies expressing
Ror2 in HEK293 cells have focused on concomitant treatment
of Wnt3a and Wnt5a but have not elaborated how Ror2
expression may also potentiateWnt3a canonical signaling or
examine the potential for differential signaling (18, 29). To
further examine Ror2 contributions as a mediator of canon-
ical -catenin signaling in RCC, we utilized 786-0 and
HEK293T cells expressing either a tetracycline-dependent
fusion protein, Ror2-GFP, or a GFP control. Robust expres-
sion of Ror2 mRNA was observed in 786-0 Ror2-overex-
pressing cells, relative to control GFP cells, following the
addition of doxycycline and remained unaltered by treat-
ment with Wnt3a (Fig. 4A). Upon expression of Ror2, there
was a significant increase in basal Axin2 mRNA as well as a
heightened response to Wnt3a treatment (Fig. 4B). This
enhancement of -catenin-mediated transcription in the
absence of Wnt3a with expression of Ror2 and further
FIGURE 4. Overexpression of Ror2 enhances -catenin-mediated transcription in renal and RCC cells. Quantitative RT-PCR for Ror2 in 786-0 (A) and
HEK293Tcells (E) shows a strong induction of Ror2 following treatment with doxycycline (500 ng/ml) and concordant significant increase in basal expression
of the canonical Wnt target gene Axin2 that is further heightened upon the addition of Wnt3a (100 ng/ml) relative to the control cells (B and F). Quantitative
RT-PCR in 786-0 (C) and 293T (G) cells for Axin2 again shows an increase in basal levels with Ror2 expression and a significant increase in response to treatment
with LiCl (10 mM). For all quantitative RT-PCR assays, transcript values were normalized to the -actin RNA internal standard, with fold change calculated in
reference to unstimulated GFP-expressing cells. D, the expression of Ror2 in 786-0 transfected with a TOPFlash luciferase reporter exhibited a significant
increase in activity basally, with Ror2 expression leading to a significant increase in response to Wnt3a (100 ng/ml) stimulation. H, HEK293T cells transfected
with a TOPFlash luciferase reporter displayed a significantly enhanced response to Wnt3a (100 ng/ml) stimulation. Error bars represent S.E. across triplicates in
duplicate experiments. p values were calculated using one-way ANOVA. *, p  0.05; **, p  0.001.
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potentiation was also observed in 786-0 cells transfected
with a TOPFlash luciferase reporter (Fig. 4D).
To validate these findings in an additional renal-derived cell
background, we used HEK293T cells expressing either GFP or
Ror2. Upon the induction of Ror2 in HEK293T cells, we again
observed a significant enhancement of Axin2 transcription and
a further increase following stimulation with Wnt3a (Fig. 4F).
Likewise,-cateninmediated transcriptionmeasured using the
TOPFlash luciferase reporter showed an enhanced response
to Wnt3a stimulation, although no significant change was
detected under basal conditions (Fig. 4H). Inhibition ofGSK3-
with LiCl resulted in an additive effect of Axin2 transcription
with Ror2 expression, suggesting that Ror2 effects aremediated
through -catenin (Fig. 4, C and G).
Ror2 Expression Results in an Increased Pool of Stable
-Catenin Independent of Exogenous Wnt Stimulation—Both
TCF-luciferase reporters and target gene expression of Axin2
demonstrated that Ror2 expression is associated with height-
ened -catenin target gene transcription in response toWnt3a
stimulation. In addition, expression of Ror2 resulted in an
enhanced transcriptional activity in the absence of exogenous
ligand. Therefore, we sought to determine whether these find-
ings also correlated with the availability of -catenin for tran-
scriptional activation.
To examine the pool of cytosolic -catenin available for
signaling, protein lysates were incubated with concanavalin-
A-Sepharose beads. Immunoblot analysis of 786-0 cell
lysates revealed an increase of free -catenin levels (indi-
cated with an asterisk, compared with total levels) upon
expression of Ror2, with a further increase following stimu-
lation with Wnt3a CM (Fig. 5A). These results were corrob-
orated in HEK293T cells, demonstrating increased stabilized
-catenin upon Ror2 expression that is enhanced with the
addition of Wnt3a CM in comparison to GFP expressing
cells (Fig. 5B). Quantification of stabilized -catenin relative
to total -catenin is shown below the corresponding bands
in each immunoblot analysis.
Tounderstand themechanismRor2 could be using to initiate
this poised signaling state, we examined upstream pathway
components. Dishevelled proteins (DVL2 and DVL3) play an
important role in canonical Wnt signaling, and DVL protein
activation via phosphorylation has been reported previously as
a mediator of Ror2 signaling (21, 32, 33). Expression of Ror2 in
786-0 and HEK293T cells resulted in increased levels of phos-
phorylated DVL2 andDVL3, detected as a shift from the faster-
migrating band to a slower-migrating phosphorylated form
indicative of activation (Fig. 5, A and B). Quantitation of pDVL
signal relative to total DVL demonstrates increased activation
FIGURE 5. Ror2 expression results in an increased pool of stable -catenin independent of exogenous Wnt stimulation. Immunoblot analysis for the
indicated antibodies of whole cell lysates or concanavalin A-treated lysates (asterisk) following stimulation with either control or Wnt3a CM (dilution 1:2) for 1 h.
786-0 (A) and HEK293T (B) cells show increased levels of phosphorylated DVL2, DVL3, and stable -catenin with Ror2 expression and an additional increase of
stable -catenin following treatment with Wnt3a CM. C, 786-0 shRor2 knockdown cell lines exhibited attenuated levels of stable -catenin basally and in
response to Wnt3a CM stimulation in comparison to 786-0 RC3 control cells. Changes in pDVL2, pDVL3, and stable -catenin relative to unphosphorylated DVL
or total -catenin are shown with densitometric quantification below the corresponding bands. LC, loading control.
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seen with Ror2 expression and, additionally, in response to
Wnt3a.
We also examined the receptor LRP6 established previously
to be required for Wnt ligand induced -catenin signaling in
mice andXenopus (30, 31). However, although we observed the
expression of LRP6 and its phosphorylation in response to
Wnt3a stimulation, no effect was observed related to Ror2
expression (Fig. 5, A–C). These data suggest that Ror2 expres-
sion mediates an LRP6-independent signal, resulting in
DVL2/3 activation and subsequent stabilization of -catenin.
However, the Wnt-ligand-enhanced signal proceeds via LRP6
phosphorylation.
When we examined suppression of Ror2, 786-0 cells demon-
strated no effect on LRP activation in response to Wnt3a, con-
sistentwith the previous overexpression studies (Fig. 5C). How-
ever, Ror2 shRNA abrogated the stabilized -catenin both
basally and upon Wnt3a CM stimulation (Fig. 5C). The extent
of suppression of Ror2 protein differs between the two shRNAs,
targeting different sequences in Ror2, with the more potent
hairpin, shRor2.2, eliciting the most significant reduction in
-catenin stabilization with or without Wnt3a. This is demon-
strated visually as well as quantitatively.
Ror2-dependent Stabilization of -Catenin Is Independent of
LRP6—To further determine what contribution the coreceptor
LRP6hason theRor2effects in-catenin-dependent signaling,we
utilized siRNA targeting to deplete cells of LRP6. Suppression of
the coreceptor LRP6 resulted in the loss of -catenin stabilization
following treatment with Wnt3a CM in GFP control cells. How-
ever, the increased basal -catenin concordant with Ror2 expres-
sion remained unaltered (Fig. 6A). We did observe repression of
the stimulated signal at the level of Axin2 transcription with
siLRP6 in both GFP and Ror2-expressing cells, although in
HEK293T cells, the basal increased level of Axin2 transcript was
lost on LRP6 suppression (Fig. 6C).
Dickkopf 1 (DKK1) is an established Wnt antagonist that
binds to LRP5/6, leading to its internalization from the cell
FIGURE 6. Ror2-dependent stabilization of -catenin is independent of LRP6. A, immunoblot analysis for the indicated antibodies of either whole cell
lysates or concanavalin A bead-treated lysates (asterisk) from 293T cells 48 h post-transfection with siCon (nonspecific control) or siLRP6 and stimulated with
either control or Wnt3a CM (dilution 1:2) for 1 h shows that increased levels of -catenin are maintained with Ror2 expression. B, immunoblot analysis for the
indicated antibodies of whole cell lysates or concanavalin A-treated lysates (asterisk) following stimulation with either Wnt3a CM (dilution 1:2) or DKK1 (400
ng/ml) for 1 h followed by Wnt3a CM stimulation showed increased levels of -catenin concurrent with Ror2 expression. LC, loading control. Quantitative
RT-PCR for Axin2 in HEK293T cells (C) transfected with siCon or siLRP6 and stimulated 48 h post transfection with Wnt3a (100 ng/ml) show that LRP6 is
needed for mediating Wnt3a/-catenin-dependent transcription. D, Axin2 expression is shown in 293T cells stimulated with either Wnt3a (100 ng/ml)
or DKK1 (400 ng/ml) for 1 h followed by Wnt3a stimulation, with high DKK1 inhibiting the response to Wnt3a stimulation in both GFP- and Ror2-
expressing cells. For all quantitative RT-PCR assays, transcript values were normalized to the -Actin RNA internal standard, with fold change calculated
in reference to unstimulated GFP-expressing cells. Error bars represent S.E. across triplicates in duplicate experiments. p values were calculated using
one-way ANOVA. *, p  0.05; *, p  0.001.
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surface. Pretreatment of HEK293T cells with recombinant
human DKK1 prior to the addition of Wnt3a CM resulted in
decreased stabilization of -catenin in GFP control cells. How-
ever, this addition of DKK1 precedingWnt3a CMhad no bear-
ing on the increased -catenin pool associated with Ror2
expression (Fig. 6B). Quantitative RT-PCR for Axin2 in
DKK1-treated cells, likewise, showed maintenance of higher
basal levels of transcription than control cells but with a loss
of response to Wnt3a stimulation (Fig. 6D). Together, these
data suggest that the LRP6 cofactor is important primarily to
transduce the Wnt3a ligand-driven enhanced signal. How-
ever, the reduction of the basal target gene transcript by
LRP6 siRNA indicates that LRP6 may retain a minor role in
mediating this signal.
An Intact Ror2 Kinase Domain Is Required for Poised Wnt
Signaling State—To determine whether Ror2 is directly con-
tributing to these changes in canonical Wnt signaling, site-di-
rected mutagenesis was used to disrupt the putative Ror2
kinase domain. Ror2-DM contains mutations in two key resi-
dues of the catalytic site, lysine 507 within the putative ATP
binding pocket and aspartate 633 of the DFG (found as DLG in
Ror2) motif. This mutant version, despite being expressed at
similar levels in 786-0 cells as wild-type Ror2, failed to effec-
tively stabilize -catenin (Fig. 7A). A similar pattern of
increased stable -catenin levels is seen in HEK293T cells
with overexpression of wild-type Ror2 but not with expres-
sion of the DM mutant (Fig. 7B). This effect is also shown
quantitatively below the corresponding immunoblot analy-
ses (Fig. 7, A and B). Quantitative RT-PCR for Axin2 also
shows a significant decrease with the expression of mutant
Ror2 (Ror2-DM) in comparison with wild-type Ror2 in both
786-0 (Fig. 7C) and HEK293T cells (D). Thus, an intact Ror2
kinase domain is necessary for achieving the increased pool
of stabilized -catenin and for canonical transcript activity
independent of Wnt3a stimulation.
DISCUSSION
Renal cell carcinoma has historically been a cancer that chal-
lenges conventional paradigms. Canonical Wnt signaling dis-
regulation is associated with tumorigenesis and progression of
RCC, transduced by a previously unknown set of mediating
factors (22–24, 34) Furthermore, increased expression of vari-
ousWnt ligands, includingWnt3a, have been observed in RCC
tumors (34). We sought to identify what role Ror2 played as a
Wnt signaling mediator in RCC because it is capable of engag-
ing a variety of canonical and noncanonicalWnt ligands (17). In
kidney tumors, we show that canonical -catenin target genes,
including Axin2, positively correlate with Ror2 expression. A
translational validation of these results is seen with the multi-
tude of target and canonical component genes showing corre-
lated expression with Ror2 in RCC cells and primary human
tumors, including PYGO1, SFRP1, and SFRP4.
Our data with both kidney-derived cells and kidney cancer
cell lines show that Ror2 expression results in a state of basally
enhanced canonical transcriptional signaling because of
DVL activation and an increased pool of stabilized, soluble
-catenin. Stimulation of Ror2-expressing cells with Wnt3a
further enhances the -catenin pool and transcriptional
response (Fig. 8).
The canonical signal cascade requires the canonical corecep-
tor LRP6 for pathway activation in response to Wnt3a because
we observed consistent inhibition with siLRP6 or DKK1 of
-catenin stabilization as well as Axin2 transcription with the
concurrent addition of Wnt3a. Inhibition or knockdown of
LRP6, however, showed little effect on the increased pool of
stabilized -catenin associated with Ror2 expression in the
absence of Wnt3a. This result would suggest that the Ror2-de-
pendent tonic signal to stabilize -catenin and enhance tran-
scriptional signals is independent of LRP6. However, siRNA
targeting of LRP6, but not inhibition with DKK1, inhibited the
enhanced basal levels of Axin2 expression seen with Ror2,
allowing the possibility that Ror2 also involves LRP6 in main-
taining this tonic state of canonicalWnt signaling. Recent work
has demonstrated that-catenin remains bound in the destruc-
tion complex and thatWnt stimulation inhibits -catenin deg-
radation, leading to saturation of the complex. As a result,
-catenin accumulates in the cytosolic pool, is then transported
FIGURE 7. Ror2 activity is required for a poised Wnt signaling state. Immu-
noblot analysis of whole cell lysates or concanavalin A-treated lysates (asterisk)
from 786-0 (A) or HEK293T cells (B) expressing GFP, Ror2, or the double mutant
Ror2-DM 48 h post induction with doxycycline (500 ng/ml) show increased levels
of stable -catenin with wild-type Ror2 compared with Ror2-DM. Densitometry
quantification of stabilized -catenin relative to total -catenin is provided below
the corresponding bands. LC, loading control. Quantitative RT-PCR for Ror2 in
786-0 (C) or HEK293T (D) cells shows expression of Ror2 and Ror2-DM cells 24 h
post-induction but a significant decrease of Axin2 expression in Ror2-DM expres-
sion in both cell lines. For all quantitative RT-PCR assays, transcript values were
normalized to the -actin RNA internal standard, with fold change calculated in
reference to unstimulated GFP-expressing cells. Error bars represent S.E. across
triplicates of a representative duplicated experiment. p values were calculated
using one-way ANOVA. *, p  0.05; **, p  0.001.
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into the nucleus, and binds to various target genes (2). These
data suggest that Ror2 can play a role in regulating this available
and active pool of -catenin. The increase in measurable solu-
ble -catenin appears to occur independently of LRP6 cofactor
recruitment. However, LRP6 may contribute to the transcrip-
tional activation of target genes, perhaps via a nuclear influx of
-catenin that is not reflected in the soluble pool in the absence
of LRP6 or an alternate mechanism.
Ror2 has been shown to mediate activation of various
homologs of DVL, key signaling members in multiple Wnt
pathways (21, 32, 33). Our data show that Ror2 expression
results in an increase in activated (phosphorylated) DVL2/3 in
both 786-0 and HEK293T cells. These results, combined with
the previous findings in the field, suggest DVL molecules as
possible substrates for the kinase activity of Ror2. However, the
potential for intermediate substrates or activators of DVL fam-
ily members cannot be excluded on the basis of these findings.
These findings highlight several points relevant to Wnt sig-
naling and tumor biology. First, this model demonstrates that
Ror2 activity may be multidimensional. We observed substan-
tial changes in canonical signalingwith Ror2 expression in RCC
and renal-derived cell lines, in contrast to previous studies with
Ror2 expression having no effect on -catenin accumulation in
response to Wnt3a (33). These expanding cell line-specific
roles of Ror2 can likely be attributed, at least in part, to available
coreceptors as well as access to Wnt ligands. LRP5/6 is well
established as part of the heterodimer responding to Wnt
ligand binding. Although Ror2 expression results in Wnt3a-
independent, -catenin-dependent stabilization and signaling,
the dependence on the expression of LRP6 for Wnt induction
exhibits the need for additional coreceptors for amplifying this
signaling cascade from the poised state. Fzd2, which was previ-
ously reported to cooperate with Ror2 enhancement of canon-
ical Wnt signaling (16), correlated with Ror2 expression in our
set of human RCC tumors, represents a candidate cofactor in
this regard, highlighting the future need for a comprehensive
understanding of Ror2 interactions with possible coreceptors
within the greater cellular context of cancer signaling.
On the basis of these observations, it is essential to examine
cell signaling effects with an emphasis toward differential states
of activation. Signals emanating from Wnt receptors such as
Ror2 may produce partial or incomplete activation of the
-catenin transcriptional response repertoire, a featurewehave
labeled as a poised state of signaling. Engagement of the canon-
icalWnt3a ligand, expressed in RCC tumors, produces a robust
enhancement that is dependent on the availability of the core-
ceptor LRP6 and exceeds the Wnt3a induced signal in the
absence of Ror2. Together, this model system sheds light on
the specific activity of Ror2 signaling in renal cancer and on the
complex nature of this signaling pathway, whichmay be critical
for dissecting these events in understanding cancer progres-
sion. Furthermore, this model highlights the potential for a
tumor modulator to effect moderate pathway activation in a
way that primes the pathway for a more intense response when
ligand or other sources of stimulation become available.
Ultimately, it is increasingly apparent that Ror2 expression in
cancers advances signals that provide a variety of advantages for
tumor progression. With Ror2 serving as a mediator of
-catenin-dependent signaling in RCC cells and tumors, it pro-
vides a highly promising therapeutic target for RCC.
Acknowledgments—We thank the members of the Rathmell labora-
tory, the University of North Carolina Lineberger Tissue Procurement
Facility; the University of North Carolina Lineberger Tissue Culture
Facility, and the University of North Carolina Lineberger Genomics
Core Facility.
REFERENCES
1. Majid, S., Saini, S., and Dahiya, R. (2012) Wnt signaling pathways in uro-
logical cancers. Past decades and still growing.Mol. Cancer 11, 7
2. Li, V. S., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus,W. R., Gerlach, J. P.,
Mohammed, S., Heck, A. J., Maurice, M. M., Mahmoudi, T., and Clevers,
H. (2012)Wnt signaling through inhibition of-catenin degradation in an
FIGURE 8. Ror2/Wnt3a signaling in RCC cells. Schematic overview of Ror2/Wnt3a signaling in RCC cells. A, in canonical Wnt signaling in the absence of either
Wnt ligand or Ror2 expression, -catenin is degraded by the proteasome. B, however, with the expression of Ror2, DVL becomes phosphorylated, leading to
stabilization of -catenin and its translocation into the nucleus, driving transcription of target genes (i.e. Axin2). C, in cells expressing Ror2 and stimulated with
Wnt3a, a further enhancement of -catenin stabilization and amplified transcription of target genes is observed.
Ror2 Creates a Poised State of Wnt Signaling in RCC
SEPTEMBER 6, 2013 • VOLUME 288 • NUMBER 36 JOURNAL OF BIOLOGICAL CHEMISTRY 26309
intact Axin1 complex. Cell 149, 1245–1256
3. Angers, S., and Moon, R. T. (2009) Proximal events in Wnt signal trans-
duction. Nat. Rev. Mol. Cell Biol. 10, 468–477
4. Wright, T. M., Brannon, A. R., Gordan, J. D., Mikels, A. J., Mitchell, C.,
Chen, S., Espinosa, I., van de Rijn, M., Pruthi, R., Wallen, E., Edwards, L.,
Nusse, R., and Rathmell, W. K. (2009) Ror2, a developmentally regulated
kinase, promotes tumor growth potential in renal cell carcinoma. Onco-
gene 28, 2513–2523
5. Edris, B., Espinosa, I., Mühlenberg, T., Mikels, A., Lee, C. H., Steigen, S. E.,
Zhu, S.,Montgomery, K. D., Lazar, A. J., Lev, D., Fletcher, J. A., Beck, A. H.,
West, R. B., Nusse, R., and van de Rijn, M. (2012) ROR2 is a novel prog-
nostic biomarker and a potential therapeutic target in leiomyosarcoma
and gastrointestinal stromal tumour. J. Pathol. 227, 223–233
6. Lu, B. J., Wang, Y. Q., Wei, X. J., Rong, L. Q., Wei, D., Yan, C. M., Wang,
D. J., and Sun, J. Y. (2012) Expression of WNT-5a and ROR2 correlates
with disease severity in osteosarcoma.Mol. Med. Rep. 5, 1033–1036
7. O’Connell, M. P., Fiori, J. L., Xu, M., Carter, A. D., Frank, B. P., Camilli,
T. C., French, A. D., Dissanayake, S. K., Indig, F. E., Bernier, M., Taub,
D. D., Hewitt, S. M., and Weeraratna, A. T. (2010) The orphan tyrosine
kinase receptor, ROR2, mediates Wnt5A signaling in metastatic mela-
noma. Oncogene 29, 34–44
8. Kobayashi,M., Shibuya, Y., Takeuchi, J.,Murata,M., Suzuki, H., Yokoo, S.,
Umeda, M., Minami, Y., and Komori, T. (2009) Ror2 expression in squa-
mous cell carcinoma and epithelial dysplasia of the oral cavity.Oral. Surg.
Oral. Med. Oral. Pathol. Oral. Radiol. Endod. 107, 398–406
9. Yamamoto,H., Oue,N., Sato, A., Hasegawa, Y., YamamotoH.,Matsubara,
A., Yasui, W., and Kikuchi, A. (2010) Wnt5a signaling is involved in the
aggressiveness of prostate cancer and expression of metalloproteinase.
Oncogene 29, 2036–2046
10. Wright, T. M., and Rathmell, W. K. (2010) Identification of Ror2 as a
hypoxia-inducible factor target in vonHippel-Lindau-associated renal cell
carcinoma. J. Biol. Chem. 285, 12916–12924
11. Takeuchi, S., Takeda, K., Oishi, I., Nomi, M., Ikeya, M., Itoh, K., Tamura,
S., Ueda, T., Hatta, T., Otani, H., Terashima, T., Takada, S., Yamamura,H.,
Akira, S., and Minami, Y. (2000) Mouse Ror2 receptor tyrosine kinase is
required for the heart development and limb formation. Genes Cells 5,
71–78
12. Afzal, A. R., Rajab, A., Fenske, C. D., Oldridge, M., Elanko, N., Ternes-
Pereira, E., Tüysüz, B., Murday, V. A., Patton, M. A., Wilkie, A. O., and
Jeffery, S. (2000) Recessive Robinow syndrome, allelic to dominant
brachydactyly type B, is caused by mutation of ROR2. Nat. Genet. 25,
419–422
13. Oldridge, M., Fortuna, A. M., Maringa, M., Propping, P., Mansour, S.,
Pollitt, C., DeChiara, T.M., Kimble, R. B., Valenzuela, D.M., Yancopoulos,
G.D., andWilkie, A.O. (2000)Dominantmutations in ROR2, encoding an
orphan receptor tyrosine kinase, cause brachydactyly type B. Nat. Genet.
24, 275–278
14. Al-Shawi, R., Ashton, S. V., Underwood, C., and Simons, J. P. (2001) Ex-
pression of the Ror1 and Ror2 receptor tyrosine kinase genes during
mouse development. Dev. Genes Evol. 211, 161–171
15. Matsuda, T., Nomi, M., Ikeya, M., Kani, S., Oishi, I., Terashima, T.,
Takada, S., and Minami, Y. (2001) Expression of the receptor tyrosine
kinase genes, Ror1 and Ror2, duringmouse development.Mech. Dev. 105,
153–156
16. Li, C., Chen,H., Hu, L., Xing, Y., Sasaki, T., Villosis,M. F., Li, J., Nishita,M.,
Minami, Y., and Minoo, P. (2008) Ror2 modulates the canonical Wnt
signaling in lung epithelial cells through cooperationwith Fzd2.BMCMol.
Biol. 9, 11
17. Billiard, J., Way, D. S., Seestaller-Wehr, L. M., Moran, R. A., Mangine, A.,
and Bodine, P. V. (2005) The orphan receptor tyrosine kinase Ror2 mod-
ulates canonical Wnt signaling in osteoblastic cells. Mol. Endocrinol. 19,
90–101
18. Mikels, A. J., and Nusse, R. (2006) Purified Wnt5a protein activates or
inhibits -catenin-TCF signaling depending on receptor context. PLoS
Biol. 4, e115
19. Laird, D. J., Altshuler-Keylin, S., Kissner, M. D., Zhou, X., and Anderson,
K. V. (2011) Ror2 enhances polarity and directional migration of primor-
dial germ cells. PLoS Genet. 7, e1002428
20. Schambony,A., andWedlich,D. (2007)Wnt-5A/Ror2 regulate expression
of XPAPC through an alternative noncanonical signaling pathway. Dev.
Cell 12, 779–792
21. Ho, H. Y., Susman, M. W., Bikoff, J. B., Ryu, Y. K., Jonas, A. M., Hu, L.,
Kuruvilla, R., andGreenberg,M. E. (2012)Wnt5a-Ror-Dishevelled signal-
ing constitutes a core developmental pathway that controls tissue mor-
phogenesis. Proc. Natl. Acad. Sci. U.S.A. 109, 4044–4051
22. Choi, H., Chun, Y. S., Kim, T. Y., and Park, J. W. (2010) HIF-2 enhances
-catenin/TCF-driven transcription by interacting with -catenin. Can-
cer -Res. 70, 10101–10111
23. Chitalia, V. C., Foy, R. L., Bachschmid, M.M., Zeng, L., Panchenko, M. V.,
Zhou, M. I., Bharti, A., Seldin, D. C., Lecker, S. H., Dominguez, I., and
Cohen, H. T. (2008) Jade-1 inhibits Wnt signalling by ubiquitylating
-catenin and mediates Wnt pathway inhibition by pVHL.Nat. Cell Biol.
10, 1208–1216
24. Peruzzi, B., Athauda, G., and Bottaro, D. P. (2006) The vonHippel-Lindau
tumor suppressor gene product represses oncogenic -catenin signaling
in renal carcinoma cells. Proc. Natl. Acad. Sci. U.S.A. 103, 14531–14536
25. Iliopoulos, O., Kibel, A., Gray, S., and Kaelin, W. G., Jr. (1995) Tumour
suppression by the human von Hippel-Lindau gene product.Nat. Med. 1,
822–826
26. Angers, S., Thorpe, C. J., Biechele, T. L., Goldenberg, S. J., Zheng, N.,
MacCoss, M. J., and Moon, R. T. (2006) The KLHL12-Cullin-3 ubiquitin
ligase negatively regulates the Wnt--catenin pathway by targeting Di-
shevelled for degradation. Nat. Cell Biol. 8, 348–357
27. O’Connell, R. M., Balazs, A. B., Rao, D. S., Kivork, C., Yang, L., and Balti-
more, D. (2010) Lentiviral vector delivery of human interleukin-7 (hIL-7)
to human immune system (HIS)mice expands T lymphocyte populations.
PLoS ONE 5, e12009
28. Teng, B. L., Hacker, K. E., Chen, S., Means, A. R., and Rathmell, W. K.
(2011) Tumor suppressive activity of prolyl isomerase Pin1 in renal cell
carcinoma.Mol. Oncol. 5, 465–474
29. Mikels, A., Minami, Y., and Nusse, R. (2009) Ror2 receptor requires tyro-
sine kinase activity to mediate Wnt5A signaling. J. Biol. Chem. 284,
30167–30176
30. Pinson, K. I., Brennan, J., Monkley, S., Avery, B. J., and Skarnes, W. C.
(2000) An LDL-receptor-related proteinmediatesWnt signalling inmice.
Nature 407, 535–538
31. Tamai, K., Semenov, M., Kato, Y., Spokony, R., Liu, C., Katsuyama, Y.,
Hess, F., Saint-Jeannet, J. P., and He, X. (2000) LDL-receptor-related pro-
teins in Wnt signal transduction. Nature 407, 530–535
32. Yamagata, K., Li, X., Ikegaki, S., Oneyama, C., Okada, M., Nishita, M., and
Minami, Y. (2012) Dissection of Wnt5a-Ror2 signaling leading to matrix
metalloproteinase (MMP-13) expression. J. Biol. Chem. 287, 1588–1599
33. Nishita, M., Itsukushima, S., Nomachi, A., Endo, M., Wang, Z., Inaba, D.,
Qiao, S., Takada, S., Kikuchi, A., and Minami, Y. (2010) Ror2/Frizzled
complex mediates Wnt5a-induced AP-1 activation by regulating Dishev-
elled polymerization.Mol. Cell Biol. 30, 3610–3619
34. Hsu, R. J., Ho, J. Y., Cha, T. L., Yu, D. S., Wu, C. L., Huang, W. P., Chu, P.,
Chen, Y. H., Chen, J. T., and Yu, C. P. (2012)WNT10A plays an oncogenic
role in renal cell carcinoma by activating WNT/-catenin pathway. PLoS
ONE 7, e47649
Ror2 Creates a Poised State of Wnt Signaling in RCC
26310 JOURNAL OF BIOLOGICAL CHEMISTRY VOLUME 288 • NUMBER 36 • SEPTEMBER 6, 2013
